ArticleNanomaterials (Basel, Switzerland)2022
Biosynthesis and Characterization of Silver Nanoparticles from the Extremophile Plant
Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 33 citations in OpenAlex.
- Rifabutin Loaded Biogenic Silver Nanoparticles: Development, Characterization, and Evaluation of Antidiabetic Activity in Streptozotocin Induced Diabetic Rats.Chemistry & biodiversity · 2026Article
- Green synthesis of silver nanoparticles using Achillea arabica and their antioxidant, anti-inflammatory, antidiabetic, and antimicrobial activities.Discover nano · 2026Article
- In Vivo Therapeutic Potential of Biologically Synthesized Nanoparticles From Pine Needle Leaf Extract in Streptozotocin-Induced Diabetic Rats.BioMed research international · 2026Article
- Green Synthesis of Ag/AgCl Nanoparticles From Argan Oil Waste: Characterization, Antibacterial, and Cytotoxicity Activities.Food science & nutrition · 2025Article
- Biosynthesized Silver Nanoparticles and Their Antidiabetic Potential.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Withania coagulans-mediated green synthesis of silver nanoparticles: characterization and assessment of their phytochemical, antioxidant, toxicity, and antimicrobial activities.BMC plant biology · 2025Article
- Engineered Nanomaterials for Environmental and Health Applications.Nanomaterials (Basel, Switzerland) · 2025Article
- Biosynthesis of silver nanoparticles from macroalgae Hormophysa triquetra and investigation of its antibacterial activity and mechanism against pathogenic bacteria.Scientific reports · 2025Article
- Biogenic synthesis of silver nanoparticles usingBiotechnology notes (Amsterdam, Netherlands) · 2025Article
- Biosynthesis and Characterization ofInternational journal of molecular sciences · 2024Article
- Green Synthesis of Silver Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2023Article
- Green Synthesis and Characterization of Novel Silver Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2023Article
- Potential Treatment of DermatophyteMolecules (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
Abstract
The present paper described the first green synthesis of silver nanoparticles (AgNPs) from the extremophile plant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.